Fig. 6From: Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastomaSummarizing scheme for the known and newly identified molecular features associated to TMZ response in GBM. References supporting the associations are shown next to the arrows [18, 35, 41,42,43,44,45]. Features with gray dotted lines are the proposed association from this study. Small arrows pointing upward inside the bubbles indicate activated signaling or highly expressedBack to article page